Your browser doesn't support javascript.
loading
QiangGuYin Modulates the OPG/RANKL/RANK Pathway by Increasing Secretin Levels during Treatment of Primary Type I Osteoporosis.
Li, Xuefei; Cui, Longkang; Chen, Wenhua; Fang, Yuan; Shen, Gaobo; Li, Zhen; Zhang, Bingbing; Wu, Lianguo.
Affiliation
  • Li X; Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China.
  • Cui L; The Second Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou 310005, China.
  • Chen W; School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
  • Fang Y; Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China.
  • Shen G; Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China.
  • Li Z; Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China.
  • Zhang B; The Second Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou 310005, China.
  • Wu L; The Second Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou 310005, China.
Evid Based Complement Alternat Med ; 2021: 7114139, 2021.
Article in En | MEDLINE | ID: mdl-34754319
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Evid Based Complement Alternat Med Year: 2021 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Evid Based Complement Alternat Med Year: 2021 Type: Article Affiliation country: China